Long-Term Outcomes Following Transarterial Embolisation of Proximal Type I Endoleaks Post-EVAR.


Journal

Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 17 08 2022
accepted: 12 12 2022
medline: 31 3 2023
pubmed: 28 1 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

To describe the long-term outcomes following transarterial embolisation for type Ia endoleaks (ELIa) in patients who failed or were unsuitable for standard endovascular/surgical options. A retrospective single-centre observational study was performed between October 2010 and April 2018. Technical success rates and long-term outcomes were evaluated. A sub-analysis was performed comparing outcomes of covered aortic endografts and Nellix endovascular aneurysm sealing systems. A total of 34 transcatheter embolisations were performed for ELIa in 27 patients (13 endografts and 14 patients with Nellix systems). A combination of Onyx and coils was used most frequently (18/34), followed by Onyx alone (14/34) and coils alone (2/34). Technical success was achieved in 33/34 (97%) procedures . Seven early complications occurred with no immediate mortality, 5 of which involved migration/reflux of embolic into the endograft-all successfully managed via endovascular approach. Following the surveillance period (mean 25 months), 13/26 (50%) of patients were free from recurrent endoleak. Sac expansion occurred in 42% (11/26). 21/26 patients died; 6 due to aneurysm sac rupture, 10 due to unrelated causes, and 5 had no cause of death available. No significant difference in survival was found between patients with an endograft or Nellix graft-Chi-squared value - 0.011 (p < 0.05 = 3.84). Transcatheter embolisation for type Ia endoleaks is a safe and effective option in a select patient cohort-where traditional endovascular and surgical options are unsuitable or have failed. The procedure may prevent recurrence in some whilst delaying rupture and death in others.

Identifiants

pubmed: 36705707
doi: 10.1007/s00270-022-03342-5
pii: 10.1007/s00270-022-03342-5
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

428-435

Informations de copyright

© 2023. Crown.

Références

Chaikof EL, Dalman RL, Eskandari MK, et al. The society for vascular surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2-77.e2. https://doi.org/10.1016/j.jvs.2017.10.044 .
doi: 10.1016/j.jvs.2017.10.044 pubmed: 29268916
Kaufman JA. Vascular interventions. In: Kaufman JA, Lee MJ, editors. Vascular and interventional radiology: The Requisites. Elsevier Saunders; 2013. p. 86–95.
Moll FL, Powell JT, Fraedrich G, et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg. 2011;41:S1e58.
doi: 10.1016/j.ejvs.2010.09.011
Harris PL, Vallabhaneni SR, Desgranges P, et al. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. European collaborators on stent/graft techniques for aortic aneurysm repair. J Vasc Surg. 2000;32:739.
doi: 10.1067/mva.2000.109990 pubmed: 11013038
Ameli-Renani S, Pavlidis V, Morgan RA. Secondary endoleak management following TEVAR and EVAR. Cardiovasc Interv Radiol. 2020;43(12):1839–54. https://doi.org/10.1007/s00270-020-02572-9 .
doi: 10.1007/s00270-020-02572-9
Perini P, BianchiniMassoni C, Mariani E, et al. Systematic review and meta-analysis of the outcome of different treatments for type 1a endoleak after EVAR. Ann Vasc Surg. 2019;60:435-446.e1. https://doi.org/10.1016/j.avsg.2019.03.032 .
doi: 10.1016/j.avsg.2019.03.032 pubmed: 31200054
Ameli-Renani S, Pavlidis V, Morgan RA. Early and midterm outcomes after transcatheter embolization of type I endoleaks in 25 patients. J Vasc Surg. 2017;65(2):346–55. https://doi.org/10.1016/j.jvs.2016.06.101 .
doi: 10.1016/j.jvs.2016.06.101 pubmed: 28126173
Chun JY, Morgan R. Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible. Eur J Vasc Endovasc Surg. 2013;45(2):141–4. https://doi.org/10.1016/j.ejvs.2012.11.010 .
doi: 10.1016/j.ejvs.2012.11.010 pubmed: 23276679
Marchiori E, Ibrahim A, Schäfers JF, Oberhuber A. Embolization for type Ia endoleak after EVAR for abdominal aortic aneurysms: a systematic review of the literature. Biomedicines. 2022;10(6):1442. https://doi.org/10.3390/biomedicines10061442 .
doi: 10.3390/biomedicines10061442 pubmed: 35740463 pmcid: 9220150
Golzarian J, Struyven J, Abada HT, Wery D, Dussaussois L, Madani A, Ferreira J, Dereume JP. Endovascular aortic stent-grafts: transcatheter embolization of persistent perigraft leaks. Radiology. 1997;202:731–4.
doi: 10.1148/radiology.202.3.9051026 pubmed: 9051026
Amesur NB, Zajko AB, Orons PD, Makaroun MS. Embolo-therapy of persistent endoleaks after endovascular repair of abdominal aortic aneurysm with the Ancure-endovascular technologies endograft system. J Vasc Interv Radiol. 1999;10:1175–82.
doi: 10.1016/S1051-0443(99)70217-4 pubmed: 10527194
Faries PL, Cadot H, Agarwal G, Kent KC, Hollier LH, Marin ML. Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. J Vasc Surg. 2003;37:1155–61.
doi: 10.1016/S0741-5214(03)00084-3 pubmed: 12764258
Maldonado TS, Rosen RJ, Rockman CB, Adelman MA, Bajakian D, Jacobowitz GR, Riles TS, Lamparello PJ. Initial successful management of type I endoleak after endovascular aortic aneurysm repair with N-Butyl cyanoacrylate adhesive. J Vasc Surg. 2003;38:664–70.
doi: 10.1016/S0741-5214(03)00729-8 pubmed: 14560210
Choi SY, Lee DY, Lee K-H, Ko Y-G, Choi D, Shim W-H, Won JY. Treatment of type I Endoleaks after endovascular aneurysm repair of infrarenal abdominal aortic aneurysm: usefulness of N-Butyl cyanoacrylate embolization in cases of failed secondary endovascular intervention. J Vasc Interv Radiol. 2011;22:155–62.
doi: 10.1016/j.jvir.2010.10.027 pubmed: 21211991
Henrikson O, Roos H, Falkenberg M. Ethylene vinyl alcohol copolymer (Onyx) to seal type 1 endoleak. New Tech Vasc. 2011;19:77–81.
Eberhardt KM, Sadeghi-Azandaryani M, Worlicek S, Koeppel T, Reiser MF, Treitl M. Treatment of type I endoleaks using transcatheter embolization with Onyx. J Endovasc Ther. 2014;21:162–71.
doi: 10.1583/13-4349MR2.1 pubmed: 24502498
Ameli-Renani S, Das R, Weller A, Chung R, Morgan RA. Embolisation of a proximal type I endoleak Post-Nellix aortic aneurysm repair complicated by reflux of Onyx into the Nellix endograft limb. Cardiovasc Interv Radiol. 2014;38:747–51.
doi: 10.1007/s00270-014-1044-5
Graif A, Vance AZ, Garcia MJ, Lie KT, McGarry MK, Leung DA. Transcatheter embolization of type I endoleaks associated with endovascular abdominal aortic aneurysm repair using ethylene vinyl alcohol copolymer. Vasc Endovasc Surg. 2017;51:28–32.
doi: 10.1177/1538574416687733
Marcelin C, Le Bras Y, Petitpierre F, Midy D, Grenier N, Ducasse E, Cornélis F. Embolization for persistent type IA endoleaks after chimney endovascular aneurysm repair with Onyx
doi: 10.1016/j.diii.2017.04.005 pubmed: 28528715
Ierardi AM, Franchin M, Fontana F, Piffaretti G, Crippa M, Angileri SA, Magenta Biasina A, Piacentino F, Tozzi M, Pinto A, et al. The role of ethylene-vinyl alcohol copolymer in association with other embolic agents for the percutaneous and endovascular treatment of type Ia endoleak. Radiol Med. 2018;123:638–42.
doi: 10.1007/s11547-018-0885-4 pubmed: 29654570
Marchiori E, Herten M, Bosiers M, Schwindt A, Bisdas T, Austermann M, Torsello G, Stavroulakis K. Effectiveness of intra-arterial aneurysm sac embolization for type Ia endoleak after endovascular aneurysm repair. J Vasc Interv Radiol. 2019;30:531–8.
doi: 10.1016/j.jvir.2018.11.028 pubmed: 30879869

Auteurs

Shyamal Patel (S)

St Georges Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, UK. shyamal.patel@stgeorges.nhs.uk.

Vyzantios Pavlidis (V)

St Georges Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, UK.

Seyed Ameli-Renani (S)

St Georges Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, UK.

Joo-Young Chun (JY)

St Georges Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, UK.

Leto Mailli (L)

St Georges Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, UK.

Robert Morgan (R)

St Georges Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH